1-3 of 3
Vivek A Upadhyay
Close
Save search
Sort by
Journal Articles

Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark

Free
Clinical Trials & Observations
Justin Taylor, Michael Haddadin, Vivek A. Upadhyay, Erwin Grussie, Neha Mehta-Shah, Andrew M. Brunner, Abner Louissaint, Jr, Scott B. Lovitch, Ahmet Dogan, Amir T. Fathi, Richard M. Stone, Martin S. Tallman, Raajit K. Rampal, Donna S. Neuberg, Kristen E. Stevenson, Steven M. Horwitz, Andrew A. Lane
Journal: Blood
Blood (2019) 134 (8): 678–687.
https://doi.org/10.1182/blood.2019001144
Published: 2019
Includes: Supplemental data
Journal Articles

Predictors of Relapse and Efficacy of Rituximab in Autoimmune Thrombotic Thrombocytopenic Purpura (TTP): A Multi-Institutional Registry-Based Analysis

Free
Lova Sun, MD, Johnathan P. Mack, MD, Ang Li, MD, Justine Ryu, MD, Vivek A Upadhyay, MD, Robert Makar, MD PhD, Pavan Bendapudi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 375.
https://doi.org/10.1182/blood-2018-99-110656
Published: 2018
Journal Articles

Projected Cost Savings of a Plasmic Score-Based Approach to Patients with Suspected Thrombotic Thrombocytopenic Purpura

Free
Vivek A Upadhyay, MD, Benjamin Geisler, MD, Lova Sun, MD, Christopher P. Stowell, MD PhD, Lynne Uhl, MD, Richard Kaufman, MD, Robert Makar, MD PhD, Pavan Bendapudi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3742.
https://doi.org/10.1182/blood.V130.Suppl_1.3742.3742
Published: 2017